Vericel Reports 3Q18 MACI Revenue of $16.4MM, +65.7% vs. 3Q17
Vericel posts another record quarter for MACI with revenue of US $16.4MM, +65.7% vs. 3Q17....
Nov 07, 2018,
Company Revenue
The NumbersConforMIS Reports 3Q18 Product Revenue of $18.3MM, +0.9% vs. 3Q17
ConforMIS posts 3Q18 product revenue of US $18.3MM, +0.9% vs 3Q17....
Nov 05, 2018, Mike Evers
OrthoPediatrics Reports 3Q18 Revenue of $15.8MM, +27.8% vs. 3Q17
OrthoPediatrics continues growth with another quarter of record revenues, reports USÂ $15.8MM in 3Q18 sales, +27.8% vs. 3Q17....
Nov 05, 2018, Mike Evers
Integra LifeSciences Reports 3Q18 Revenue
Integra LifeSciences reports 3Q18 results; ORTHOWORLD estimates orthopaedic revenue of $22.7M, -0.8% vs. 3Q17....
Nov 02, 2018, Mike Evers
NuVasive Reports 3Q18 Revenue of $271.3MM, +9.6% vs. 3Q17
NuVasive performance driven by increased case volume and new products, posts 3Q18 revenue of US $271.3MM, +9.6%vs. 3Q17....
Nov 01, 2018, Mike Evers
Sanofi Reports 3Q18 Orthobiologic Revenue of €72MM, -24.2% vs. 3Q17
Sanofi Synvisc/Synvisc-One orthobiologics revenue continues to slide, accounting for €72MM (USD $88.7MM) 3Q18 revenue, -24.2% vs. 3Q17....
Nov 01, 2018, Mike Evers
Orthofix Reports 3Q18 Revenue of $111.7MM, +6.1% vs. 3Q17
Orthofix performance driven by bone growth and trauma products with 3Q18 revenue of US $111.7MM, +6.1% vs. 3Q17....
Oct 31, 2018, Mike Evers
Stryker Reports 3Q18 Revenue of $1.6BB, +4.2% vs. 3Q17
Momentum in knee reconstruction drove Stryker's 3Q18 orthopaedic performance, with revenue of US $1,689.7MM, +4.2% vs. 3Q17....
Oct 30, 2018, Mike Evers
Zimmer Biomet Reports 3Q18 Revenue of $1,637.4MM, +1.2% vs. 3Q17
Zimmer Biomet keeps pace with recovery efforts, posts 3Q18 orthopaedic revenue of US $1,637.4MM, +1.2% vs. 3Q17....
Oct 30, 2018, Mike Evers
Anika Therapeutics Reports 3Q18 Revenue of $24.1MM, +0.4% vs. 3Q17
Anika Therapeutics posts 3Q18 orthobiologic revenue of $24.1MM, +0.4% vs. 3Q17....
Oct 26, 2018, Mike Evers
Loading new posts...
No more posts
